4. 2); betydningen af nedsat nyrefunktion for udskillelsen af atazanavir forventes dog at være minimal.
There are no pharmacokinetic data available on patients with renal insufficiency (see section 4.2); however, the impact of renal impairment on atazanavir elimination is anticipated to be minimal.